Results of disease-Free Interval (DFI) and Progression-Free Interval (PFI) analysis were also examined to adequately demonstrate that CDKN2A is a risk factor for most cancer types and is significantly associated with the prognosis of cancer. The gene discussed is CDKN2A; the disease is cancer.